查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1403411

到 2030 年临床化学分析仪市场预测：按产品、测试类型、模式、技术、应用、最终用户和地区进行的全球分析

Clinical Chemistry Analyzers Market Forecasts to 2030 - Global Analysis By Product, Test Type, Modality, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC的数据，2023年全球临床生化分析仪市场规模为141.7亿美元，预计到2030年将达到172.6亿美元，预测期内复合年增长率为6.2%。

临床化学分析仪是一种先进的医疗设备，旨在分析血液、尿液和其他体液中的各种化学成分。这些自动化系统透过测量葡萄糖、胆固醇和酵素等物质的浓度，在疾病诊断和监测中发挥重要作用。其准确性和自动化提高了临床环境中实验室诊断的可靠性和速度。

根据加拿大癌症协会2021年报告，2021年加拿大将新增约229,200例癌症病例，平均每天有628名加拿大人被诊断出罹患癌症。慢性病的增加刺激了北美地区临床化学分析仪的成长。

慢性病增加

随着糖尿病、心血管疾病和肾臟疾病等慢性疾病变得越来越普遍，对准确、及时的临床化学分析的需求也随之增加。临床化学分析仪在这些疾病的监测和管理中发挥重要作用，并且在医疗保健环境中越来越普及。随着医疗保健行业努力应对慢性病负担日益增加的挑战，这种趋势可能会持续下去，从而促进市场的持续成长。

缺乏熟练人才

由于临床化学分析的复杂性，需要经过培训的专业人员来准确操作和解释结果。这些仪器的复杂性要求人们对分析技术、测试协议和资料解释有深入​​的了解。解决此技能差距对于充分发挥临床化学分析仪的潜力至关重要，并可能阻碍普及和最佳功能。

转向个人化医疗

个人化医疗根据个人特征客製化医疗保健干预措施，以优化治疗效果。临床化学分析仪透过提供患者的详细资料、实现准确的诊断和治疗监测而发挥重要作用。随着个体化医疗保健需求的增加，先进且适应性强的分析仪器的市场可能会扩大，为临床化学领域的创新和成长开闢有希望的途径。

营运和维护成本高

临床化学分析仪由于其复杂的设计、先进的技术和严格的监管要求而导致较高的营运和维护成本。这些分析仪需要精确度和可靠性，需要复杂的组件和严格的品管。定期校准、维护和遵守不断变化的标准会增加持续的费用。这些经济挑战阻碍了市场扩张。

COVID-19 的影响

COVID-19 的爆发对临床化学分析仪市场产生了重大影响。对包括生化分析在内的诊断测试的需求不断增长，是市场成长的驱动力。然而，供应链中断、医疗机构预算削减和劳动力短缺带来了挑战。对快速、准确的测试解决方案的重视与技术的进步相结合，活性化了临床化学分析仪领域的创新。市场表现出了弹性，适应不断变化的医疗保健环境，并优先考虑满足疫情引起的诊断需求的解决方案。

便携式分析仪细分市场预计将在预测期内成为最大的细分市场

由于能够提供快速、准确的结果，便携式分析仪行业预计将出现良好的成长。便携式临床化学分析仪是一种紧凑的诊断设备，可让您随时随地测量血液样本的各种医疗参数。它旨在测量各种分析物，例如葡萄糖、胆固醇和电解质，从而可以快速诊断和监测各种医疗状况。可移植性提高了诊断能力的获取，特别是在资源有限和偏远地区。

治疗药物监测（TDM）领域预计在预测期内复合年增长率最高

治疗药物监测（TDM）领域预计在预测期内复合年增长率最高。治疗药物监测 (TDM) 对于临床化学分析仪至关重要，可确保患者获得最佳药物水平。这些分析仪测量生物样本中的药物浓度，并允许医疗保健专业人员根据个别患者的反应调整给药方案。 TDM 可提高治疗效果、最大限度地减少副作用并解决药物代谢的变异性。

比最大的地区

由于医疗基础设施的增加、慢性病盛行率的上升以及对疾病早期发现的日益重视，预计亚太地区在预测期内将占据最大的市场占有率。亚太地区是雅培实验室、西门子医疗、伯乐实验室和罗氏诊断等大公司的所在地。该地区拥有强有力的政府倡议和医疗机构发布的实践指南的高实施率。此外，全球公司的高研发投资以及该地区开拓的机会正在推动高速成长。

复合年增长率最高的地区：

由于医疗保健技术的进步和慢性病的增加，预计北美在预测期内将呈现最高的复合年增长率。该地区拥有发达的医疗基础设施和高龄化，对诊断服务的需求不断增加，并推动了临床化学分析仪市场的发展。产业主要企业专注于产品创新和策略联盟以保持竞争力。此外，自动化系统和即时测试解决方案的采用也有助于市场扩张。

提供免费客製化：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球临床生化分析仪市场：副产品

  • 桌上型分析仪
  • 落地式分析仪
  • 便携式分析仪
  • 模组化分析仪
  • 综合分析装置
  • 其他产品

第六章全球临床生化分析仪市场：依测试类型

  • 基础代谢组
  • 肝臟组
  • 电解质板
  • 血脂谱
  • 甲状腺功能检查
  • 肾功能检查
  • 特殊面板

第七章全球临床生化分析仪市场：按模式

  • 全自动分析仪
  • 半自动分析仪
  • 护理点 (POC) 分析仪

第八章全球临床生化分析仪市场：依技术分类

  • 酵素测定技术
  • 离子选择电极（ISE）技术
  • 比色技术
  • 化学冷光免疫检测（CLIA）技术
  • 萤光技术
  • 电化学生物感测器
  • 分子诊断技术

第九章全球临床生化分析仪市场：按应用

  • 定期化学测试
  • 特殊化学测试
  • 治疗药物监测（TDM）
  • 在内分泌学上的应用
  • 心臟标记测试
  • 传染病检查
  • 其他用途

第10章全球临床化学分析仪市场：依最终用户分类

  • 医院
  • 诊断实验室
  • 研究机构
  • 製药和生物技术公司
  • 学术研究中心
  • 即时检测 (POCT) 设施
  • 家庭医疗保健设置

第十一章全球临床生化分析仪市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十二章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十三章 公司简介

  • Abbott Laboratories
  • Mindray Medical International Limited
  • Siemens AG
  • F. Hoffmann-La Roche Limited
  • Danaher Corporation
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • HITACHI
  • Horiba Medical Limited
  • EKF Diagnostics
  • Roche Diagnostics
  • Ortho Clinical Diagnostics
  • Bio-Rad Laboratories
  • Randox Laboratories
  • ELITechGroup
  • DiaSorin
  • Shimadzu Corporation
  • EDAN Instruments
Product Code: SMRC24636

According to Stratistics MRC, the Global Clinical Chemistry Analyzers Market is accounted for $14.17 billion in 2023 and is expected to reach $17.26 billion by 2030 growing at a CAGR of 6.2% during the forecast period. Clinical Chemistry Analyzers are sophisticated medical instruments designed to analyze various chemical components in blood, urine, and other bodily fluids. These automated systems play a crucial role in diagnosing and monitoring diseases by measuring concentrations of substances like glucose, cholesterol, and enzymes. Their precision and automation enhance the reliability and speed of laboratory diagnostics in clinical settings.

According to the Canadian Cancer Society's 2021 report, about 229,200 new cancer cases will be diagnosed in Canada in 2021, and on average, 628 Canadians are diagnosed with cancer every day. The rising number of chronic diseases in the nation adds to the growth of clinical chemistry analyzers in the North American region.

Market Dynamics:

Driver:

Increasing prevalence of chronic diseases

The need for accurate and timely clinical chemistry analysis intensifies, as chronic conditions such as diabetes, cardiovascular diseases, and kidney disorders become more prevalent. Clinical chemistry analyzers play a crucial role in monitoring and managing these conditions, fostering their widespread adoption in healthcare settings. This trend is likely to persist, contributing to the market's sustained growth as the healthcare industry strives to address the challenges posed by the rising burden of chronic diseases.

Restraint:

Lack of skilled personnel

The complex nature of clinical chemistry analysis requires trained professionals for accurate operation and interpretation of results. The complexity of these instruments demands a workforce with a deep understanding of analytical techniques, laboratory protocols, and data interpretation. Addressing this skill gap becomes crucial for unlocking the full potential of clinical chemistry analyzers, potentially hindering their widespread adoption and optimal functionality in healthcare settings.

Opportunity:

Shift towards personalized medicine

Personalized medicine tailors healthcare interventions to individual characteristics, optimizing treatment efficacy. Clinical chemistry analyzers play a crucial role by providing detailed patient profiles, enabling precise diagnostics and treatment monitoring. As the demand for personalized healthcare rises, the market for advanced and adaptable analyzers is poised for expansion, creating a promising avenue for innovation and growth in the clinical chemistry sector.

Threat:

High operational costs & maintenance expenses

Clinical Chemistry Analyzers incur high operational costs and maintenance expenses due to their intricate design, sophisticated technology, and stringent regulatory requirements. These analyzers demand precision and reliability, necessitating complex components and rigorous quality control. Regular calibration, maintenance, and compliance with evolving standards contribute to ongoing expenses. These financial challenges collectively hamper the market expansion.

COVID-19 Impact

The COVID-19 pandemic has significantly impacted the Clinical Chemistry Analyzers market. The increased demand for diagnostic testing, including biochemical analysis, drove market growth. However, disruptions in the supply chain, reduced healthcare facility budgets, and workforce shortages posed challenges. The emphasis on rapid and accurate testing solutions, coupled with ongoing advancements in technology, stimulated innovation in the clinical chemistry analyzers sector. The market exhibited resilience, adapting to the evolving healthcare landscape and prioritizing solutions to address the diagnostic needs arising from the pandemic.

The portable analyzers segment is expected to be the largest during the forecast period

The portable analyzers segment is estimated to have a lucrative growth, due to their rapid and accurate results. Portable clinical chemistry analyzers are compact diagnostic devices that enable on-the-go testing of blood samples for various medical parameters. They are designed to measure a range of analytes, including glucose, cholesterol, and electrolytes, facilitating quick diagnosis and monitoring of various medical conditions. Their portability enhances accessibility to diagnostic capabilities, particularly in resource-limited or remote areas.

The therapeutic drug monitoring (TDM) segment is expected to have the highest CAGR during the forecast period

The therapeutic drug monitoring (TDM) segment is anticipated to witness the highest CAGR growth during the forecast period. Therapeutic Drug Monitoring (TDM) is crucial in Clinical Chemistry Analyzers to ensure optimal medication levels for patients. These analyzers measure drug concentrations in biological samples, enabling healthcare professionals to adjust dosage regimens based on individual patient responses. TDM enhances treatment efficacy, minimizes side effects, and addresses variability in drug metabolism which accelerates the segment growth.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the increasing healthcare infrastructure, rising prevalence of chronic diseases, and a growing emphasis on early disease detection. It also has the presence of major companies namely Abbott Laboratories, Siemens Healthineers, Bio-Rad Laboratories and Roche Diagnostics. The supportive government initiatives and high implementation of practice guidelines released by healthcare organizations are present across this region. Furthermore, high R&D investment by the global players and presence of unexplored opportunities in this region serve as high growth rendering drivers.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, driven by advancements in healthcare technology and the increasing prevalence of chronic diseases. The region's well-established healthcare infrastructure, coupled with a rising aging population, has led to a higher demand for diagnostic services, boosting the market for clinical chemistry analyzers. Key players in the industry are focusing on product innovation and strategic collaborations to maintain a competitive edge. Further, the adoption of automated systems and point-of-care testing solutions is contributing to market expansion.

Key players in the market:

Some of the key players profiled in the Clinical Chemistry Analyzers Market include Abbott Laboratories, Mindray Medical International Limited, Siemens AG, F. Hoffmann-La Roche Limited, Danaher Corporation, Sysmex Corporation, Thermo Fisher Scientific Inc., HITACHI, Horiba Medical Limited, EKF Diagnostics, Roche Diagnostics, Ortho Clinical Diagnostics, Bio-Rad Laboratories, Randox Laboratories, ELITechGroup, DiaSorin, Shimadzu Corporation and EDAN Instruments.

Key Developments:

In May 2023, Siemens Healthineers launched the Atellica HEMA 570 and 580 Analyzers. These analyzers are designed for high-volume hematology testing. They are intended to streamline testing by integrating automation. The analyzers also have intuitive interfaces and multi-analyzer automation connectivity.

In July 2022, EDAN Instruments launched its POC fluorescence-based CO-OX blood gas and chemistry analysis system, i20, with the capacity to analyze over 45 parameters, covering everything from blood gases to electrolytes to CO-oximetry.

In May 2022, Mindray launched the BS-600M, a powerful, efficient chemistry analyzer that is designed to empower medium-volume laboratories with increased productivity, efficiency, and reliability.

Products Covered:

  • Benchtop Analyzers
  • Floor-standing Analyzers
  • Portable Analyzers
  • Modular Analyzers
  • Integrated Analyzers
  • Other Products

Test Types Covered:

  • Basic Metabolic Panels
  • Liver Panels
  • Electrolyte Panels
  • Lipid Profiles
  • Thyroid Function Panels
  • Renal Function Panels
  • Specialty Panels

Modalities Covered:

  • Fully Automated Analyzers
  • Semi-Automated Analyzers
  • Point-of-Care (POC) Analyzers

Technologies Covered:

  • Enzymatic Assay Technology
  • Ion-Selective Electrode (ISE) Technology
  • Colorimetric Technology
  • Chemiluminescence Immunoassay (CLIA) Technology
  • Fluorescence Technology
  • Electrochemical Biosensors
  • Molecular Diagnostics Technology

Applications Covered:

  • Routine Chemistry Testing
  • Special Chemistry Testing
  • Therapeutic Drug Monitoring (TDM)
  • Endocrinology Applications
  • Cardiac Markers Testing
  • Infectious Disease Testing
  • Other Applications

End Users Covered:

  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Academic Research Centers
  • Point-of-Care Testing (POCT) Facilities
  • Home Healthcare Settings

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Clinical Chemistry Analyzers Market, By Product

  • 5.1 Introduction
  • 5.2 Benchtop Analyzers
  • 5.3 Floor-standing Analyzers
  • 5.4 Portable Analyzers
  • 5.5 Modular Analyzers
  • 5.6 Integrated Analyzers
  • 5.7 Other Products

6 Global Clinical Chemistry Analyzers Market, By Test Type

  • 6.1 Introduction
  • 6.2 Basic Metabolic Panels
  • 6.3 Liver Panels
  • 6.4 Electrolyte Panels
  • 6.5 Lipid Profiles
  • 6.6 Thyroid Function Panels
  • 6.7 Renal Function Panels
  • 6.8 Specialty Panels

7 Global Clinical Chemistry Analyzers Market, By Modality

  • 7.1 Introduction
  • 7.2 Fully Automated Analyzers
  • 7.3 Semi-Automated Analyzers
  • 7.4 Point-of-Care (POC) Analyzers

8 Global Clinical Chemistry Analyzers Market, By Technology

  • 8.1 Introduction
  • 8.2 Enzymatic Assay Technology
  • 8.3 Ion-Selective Electrode (ISE) Technology
  • 8.4 Colorimetric Technology
  • 8.5 Chemiluminescence Immunoassay (CLIA) Technology
  • 8.6 Fluorescence Technology
  • 8.7 Electrochemical Biosensors
  • 8.8 Molecular Diagnostics Technology

9 Global Clinical Chemistry Analyzers Market, By Application

  • 9.1 Introduction
  • 9.2 Routine Chemistry Testing
  • 9.3 Special Chemistry Testing
  • 9.4 Therapeutic Drug Monitoring (TDM)
  • 9.5 Endocrinology Applications
  • 9.6 Cardiac Markers Testing
  • 9.7 Infectious Disease Testing
  • 9.8 Other Applications

10 Global Clinical Chemistry Analyzers Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals
  • 10.3 Diagnostic Laboratories
  • 10.4 Research Institutes
  • 10.5 Pharmaceutical & Biotechnology Companies
  • 10.6 Academic Research Centers
  • 10.7 Point-of-Care Testing (POCT) Facilities
  • 10.8 Home Healthcare Settings

11 Global Clinical Chemistry Analyzers Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Abbott Laboratories
  • 13.2 Mindray Medical International Limited
  • 13.3 Siemens AG
  • 13.4 F. Hoffmann-La Roche Limited
  • 13.5 Danaher Corporation
  • 13.6 Sysmex Corporation
  • 13.7 Thermo Fisher Scientific Inc.
  • 13.8 HITACHI
  • 13.9 Horiba Medical Limited
  • 13.10 EKF Diagnostics
  • 13.11 Roche Diagnostics
  • 13.12 Ortho Clinical Diagnostics
  • 13.13 Bio-Rad Laboratories
  • 13.14 Randox Laboratories
  • 13.15 ELITechGroup
  • 13.16 DiaSorin
  • 13.17 Shimadzu Corporation
  • 13.18 EDAN Instruments

List of Tables

  • Table 1 Global Clinical Chemistry Analyzers Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Clinical Chemistry Analyzers Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Clinical Chemistry Analyzers Market Outlook, By Benchtop Analyzers (2021-2030) ($MN)
  • Table 4 Global Clinical Chemistry Analyzers Market Outlook, By Floor-standing Analyzers (2021-2030) ($MN)
  • Table 5 Global Clinical Chemistry Analyzers Market Outlook, By Portable Analyzers (2021-2030) ($MN)
  • Table 6 Global Clinical Chemistry Analyzers Market Outlook, By Modular Analyzers (2021-2030) ($MN)
  • Table 7 Global Clinical Chemistry Analyzers Market Outlook, By Integrated Analyzers (2021-2030) ($MN)
  • Table 8 Global Clinical Chemistry Analyzers Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 9 Global Clinical Chemistry Analyzers Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 10 Global Clinical Chemistry Analyzers Market Outlook, By Basic Metabolic Panels (2021-2030) ($MN)
  • Table 11 Global Clinical Chemistry Analyzers Market Outlook, By Liver Panels (2021-2030) ($MN)
  • Table 12 Global Clinical Chemistry Analyzers Market Outlook, By Electrolyte Panels (2021-2030) ($MN)
  • Table 13 Global Clinical Chemistry Analyzers Market Outlook, By Lipid Profiles (2021-2030) ($MN)
  • Table 14 Global Clinical Chemistry Analyzers Market Outlook, By Thyroid Function Panels (2021-2030) ($MN)
  • Table 15 Global Clinical Chemistry Analyzers Market Outlook, By Renal Function Panels (2021-2030) ($MN)
  • Table 16 Global Clinical Chemistry Analyzers Market Outlook, By Specialty Panels (2021-2030) ($MN)
  • Table 17 Global Clinical Chemistry Analyzers Market Outlook, By Modality (2021-2030) ($MN)
  • Table 18 Global Clinical Chemistry Analyzers Market Outlook, By Fully Automated Analyzers (2021-2030) ($MN)
  • Table 19 Global Clinical Chemistry Analyzers Market Outlook, By Semi-Automated Analyzers (2021-2030) ($MN)
  • Table 20 Global Clinical Chemistry Analyzers Market Outlook, By Point-of-Care (POC) Analyzers (2021-2030) ($MN)
  • Table 21 Global Clinical Chemistry Analyzers Market Outlook, By Technology (2021-2030) ($MN)
  • Table 22 Global Clinical Chemistry Analyzers Market Outlook, By Enzymatic Assay Technology (2021-2030) ($MN)
  • Table 23 Global Clinical Chemistry Analyzers Market Outlook, By Ion-Selective Electrode (ISE) Technology (2021-2030) ($MN)
  • Table 24 Global Clinical Chemistry Analyzers Market Outlook, By Colorimetric Technology (2021-2030) ($MN)
  • Table 25 Global Clinical Chemistry Analyzers Market Outlook, By Chemiluminescence Immunoassay (CLIA) Technology (2021-2030) ($MN)
  • Table 26 Global Clinical Chemistry Analyzers Market Outlook, By Fluorescence Technology (2021-2030) ($MN)
  • Table 27 Global Clinical Chemistry Analyzers Market Outlook, By Electrochemical Biosensors (2021-2030) ($MN)
  • Table 28 Global Clinical Chemistry Analyzers Market Outlook, By Molecular Diagnostics Technology (2021-2030) ($MN)
  • Table 29 Global Clinical Chemistry Analyzers Market Outlook, By Application (2021-2030) ($MN)
  • Table 30 Global Clinical Chemistry Analyzers Market Outlook, By Routine Chemistry Testing (2021-2030) ($MN)
  • Table 31 Global Clinical Chemistry Analyzers Market Outlook, By Special Chemistry Testing (2021-2030) ($MN)
  • Table 32 Global Clinical Chemistry Analyzers Market Outlook, By Therapeutic Drug Monitoring (TDM) (2021-2030) ($MN)
  • Table 33 Global Clinical Chemistry Analyzers Market Outlook, By Endocrinology Applications (2021-2030) ($MN)
  • Table 34 Global Clinical Chemistry Analyzers Market Outlook, By Cardiac Markers Testing (2021-2030) ($MN)
  • Table 35 Global Clinical Chemistry Analyzers Market Outlook, By Infectious Disease Testing (2021-2030) ($MN)
  • Table 36 Global Clinical Chemistry Analyzers Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 37 Global Clinical Chemistry Analyzers Market Outlook, By End User (2021-2030) ($MN)
  • Table 38 Global Clinical Chemistry Analyzers Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 39 Global Clinical Chemistry Analyzers Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 40 Global Clinical Chemistry Analyzers Market Outlook, By Research Institutes (2021-2030) ($MN)
  • Table 41 Global Clinical Chemistry Analyzers Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 42 Global Clinical Chemistry Analyzers Market Outlook, By Academic Research Centers (2021-2030) ($MN)
  • Table 43 Global Clinical Chemistry Analyzers Market Outlook, By Point-of-Care Testing (POCT) Facilities (2021-2030) ($MN)
  • Table 44 Global Clinical Chemistry Analyzers Market Outlook, By Home Healthcare Settings (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.